ELI LILLY$41.11
-0.05
| Last Trade: |
41.11 |
| Trade Time: |
May 25 4:52 PM Eastern Daylight Time |
| Change: |
-0.05 (-0.12 %) |
| Prev Close: |
41.16 |
| Open: |
41.11 |
| Bid: |
40.71 |
| Ask: |
41.13 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/18/2012
|
HANISH ARNOLD C
|
Chief Accounting Officer
|
-1,295
|
$40.49
|
-6.80%
|
|
5/14/2012
|
Tapiero Jacques
|
SVP&Pres., Emerging Markets
|
-2,000
|
$41.04
|
-8.75%
|
|
5/1/2012
|
Conterno Enrique A
|
Sr. VP & Pres., Lilly Diabetes
|
-5,000
|
$41.32
|
-10.64%
|
|
4/17/2012
|
Tapiero Jacques
|
SVP&Pres., Emerging Markets
|
-2,000
|
$40.00
|
-8.04%
|
|
4/2/2012
|
Conterno Enrique A
|
Sr. VP & Pres., Lilly Diabetes
|
-5,000
|
$40.30
|
-9.61%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LLY), click here.
-
The pharmaceutical giant reported decent first quarter results late in April 2012. However, It will likely be some time before Eli Lilly sees an extended period of steady, sustainable sales growth.
Read More »
-
Stocks that consistently pay sizable dividends offer important advantages to individual investors. Here are five worth a look.
Read More »
Free Reports
|
|
